| 45.18 Delayed Data As of Sep 20 |  +0.57 / +1.28%Today’s Change | 35.30 Today|||52-Week Range 45.69 | +18.96% Year-to-Date |
| Previous close | 44.61 |
| Today’s open | 45.21 |
| Day’s range | 44.96 - 45.33 |
| Volume | 4,870,606 |
| Average volume (3 months) | 3,161,997 |
| Market cap | $112.2B |
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +0.75% |
| Earnings growth (next 5 years) | +16.60% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 52.5 |
| Price/Sales | 4.36 |
| Price/Book | 8.69 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +1.54 | +3.43% |
| LLYEli Lilly and Co | +1.81 | +1.58% |
| ABBVAbbVie | +0.72 | +1.00% |
| GSKGlaxoSmithKline | +0.31 | +0.75% |
| Next reporting date | October 24, 2019 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Pascal Soriot |
Executive VP-Operations & Information Technology Pam P. Cheng |
Corporate headquarters Cambridge, Cambridgeshire |
